News

Post-PCV13 findings prompt continued surveillance


 

References

Additionally, subdural empyema on neuroimaging increased from 1% to 16%, but was not associated with any particular serotype and was not associated with the cases of hemiparesis.

Overall, 52% of survivors had some sort of neurologic sequelae at the time of discharge, but there were no differences in terms of specific sequelae between the two groups.

The rates of morbidity and mortality for pneumococcal meningitis remain substantial and have not changed significantly since introduction of PCV13, Dr. Olarte said.

However, if the number of cephalosporin nonsusceptible pneumococci isolated from children with meningitis continues to decrease, modification of empiric antibiotic selection for suspected bacterial meningitis might be considered in the future, therefore ongoing surveillance is warranted, she said.

The studies were partially supported by Pfizer. The authors reported having no other disclosures.

Pages

Recommended Reading

CDC updates guidance on protecting health care workers from Ebola
MDedge Pediatrics
WHO: Ebola vaccines may reach Africa in January
MDedge Pediatrics
Study IDs factors linked to bronchodilator use in bronchiolitis
MDedge Pediatrics
Measure associated with LOS in infants with bronchiolitis
MDedge Pediatrics
ID CONSULT: Influenza virus and pneumococci dance together
MDedge Pediatrics
Pediatric ID hospitalizations down after vaccine introductions
MDedge Pediatrics
Careful exam distinguishes molluscum from lookalikes
MDedge Pediatrics
DeSalvo leaves post to focus on Ebola response
MDedge Pediatrics
Guidelines for children’s bronchiolitis treatment issued by AAP
MDedge Pediatrics
Consider strep, not MRSA, when eczematous children suffer skin infections
MDedge Pediatrics